Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications
GlyFn is a novel biomarker for PE diagnosis and its complications, particularly at GA < 37 weeks. Prospective studies should evaluate to what degree it outperforms traditional biomarkers.
Authors
- Langeza Saleh (ORCID: https://orcid.org/0000-0001-6219-3109)
- Anna Kluivers (ORCID: https://orcid.org/0000-0002-4115-372X)
- Rugina I. Neuman (ORCID: https://orcid.org/0000-0002-2471-9461)
- W. Edward Visser (ORCID: https://orcid.org/0000-0002-5248-863X)
- A.H. Jan Danser (ORCID: https://orcid.org/0000-0002-5052-3585)
- Bhanu Kalra (ORCID: https://orcid.org/0000-0003-3643-8488)
- Ajay Kumar (ORCID: https://orcid.org/0000-0002-5777-3691)
Institutions
- Erasmus MC (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Pregnancy Hypertension
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1016/j.preghy.2024.101177
- Citations
- 4
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 2.33